Scholars Central

Research articlePublished 2014

Predictive Value of Circulating Vascular Endothelial Growth Factor-1 Level Measured Repeatedly During Long-Term Follow-Up in Patients with Arterial Hypertension after Acute Ischemic Stroke

Authors: Berezin AE, Lisovaya OA

Angiology: Open Access

Volume 2 · Issue 1 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Aim: The study aim was to investigate the predictive value of the circulating Vascular Endothelial Growth Factor-1 (VEGF-1) level measured repeatedly in hypertensive patients after acute ischemic stroke. Methods: 102 patients with mild to moderate arterial hypertension, who were evaluated within a 3-week post ischemic stroke period, were included in the study. The circulating VEGF-1 level was measured at baseline and in six months after stroke. Clinical interviews were carried out monthly for a year after stroke. The following are cardiovascular outcomes defined as clinical events: recurrent stroke or transient ischemic attack, ischemic heart disease, sudden death, diabetes mellitus, cardiovascular events, including chronic heart failure and the need for hospital admission for those reasons. Results: The analysis showed an increase in the VEGF-1 concentration, which was associated obviously with the incidence of cardiovascular events within six months after an ischemic stroke when compared with the individuals without an increase in circulating VEGF-1 levels. Adjusted Odds Ratio (OR) for the occurrence of cumulative cardiovascular events in hypertensive patients whose VEGF-1 levels were over 403.57 pg/ml at baseline in comparison with OR in those whose VEGF-1 levels were lower, was equal to 4.11 (95% CI=2.66-7.28; P=0.001). In sixth months, the higher circulating VEGF-1 level was over 450.15 pg/ml in the patients who had its level elevated at baseline in comparison with those who had its level lower at baseline, with the higher VEGF-1 level associated with adjusted odds ratio of 5.46 (95% CI =3.12-7.90; P=0.001). Defined by serial measurements, adjusted OR for the occurrence of cumulative cardiovascular events in hypertensive patients with increased circulating VEGF-1 level was 6.10 (95% CI = 4.70-8.30, P = 0.001) versus the individuals without such a change in VEGF-1 level. Conclusion: We found that incremented circulating VEGF-1 level was an independent predictor of cumulative cardiovascular events in hypertensive patients within a year after an ischemic stroke.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Angiology: Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAngiology: Open Access
  • SubjectCardiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Berezin AE”
  • BylineArticles whose byline prints “Lisovaya OA”